AV
AVNS
Market ClosedAvanos Medical, Inc.
US
2.29K employees
CEO: David C. Pacitti
Founded: 2014
$24.99
+$0.00(+NaN%)
Market Cap
1.17B
Beta
1.57
52W Range
N/A
Dividend Yield
0.00%
Forecasting Analysis
AI-powered predictions and statistical risk modeling for short-term price movements
AI Insight:
AI forecasts show strong positive short-term momentum for Avanos Medical, trending higher over 30 days. Analyst consensus projects downside risk over 12 months, with strong coverage and a tight, broadly aligned range. The divergence indicates contrasting short-term optimism versus longer-term caution, reflecting mixed investment signals.
Current Price
N/A
Last closing price
Price Prediction
Machine learning prediction based on historical price patterns
Period:
Analyst Price Target for AVNS
Loading analyst price targets...
Wall Street Forecasts
Revenue Forecast
Past Growth
N/A
Based on Historical CAGR
Forward Growth
N/A
Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
Revenue Analysis
Comparison of Actual and Estimated Revenues
Loading chart data...
Revenue growth steady at 0.0%.
Operating Profitability Forecast
Past Growth
N/A
EBITDA Historical CAGR
Forward Growth
N/A
EBITDA Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EBITDA Analysis
Comparison of Actual and Estimated EBITDA
Loading chart data...
EBITDA maintaining 0.0% trajectory.
Earnings Per Share Forecast
Past Growth
N/A
EPS Historical CAGR
Forward Growth
N/A
EPS Projected CAGR
Analyst Accuracy
0%
Estimate Accuracy
EPS Analysis
Comparison of Actual and Estimated Earnings Per Share
Loading chart data...
EPS growth stable around 0.0%.
Explore AVNS
AVNS in the Healthcare
Small Cap